(Q43589705)

English

Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells

scientific article published in June 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Lin Yang

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Liang Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hui-Kuan Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Pu-Yeh Kan

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Shaozhen Xie

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Meng-Yin Tsai

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Peng-Hui Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Yen-Ta Chen

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Chawnshang Chang

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Biochemical and Biophysical Research Communications

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

305

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

462-469

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Interleukin 6 receptor mRNA in prostate carcinomas and benign prostate hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Characterization of the role of IL-6 in the progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Interleukin-6 and epidermal growth factor promote anchorage-independent growth of immortalized human prostatic epithelial cells treated with N-methyl-N-nitrosourea

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Interleukin-6: a candidate mediator of human prostate cancer morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Molecular Cloning of Human and Rat Complementary DNA Encoding Androgen Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Differential induction of the androgen receptor transcriptional activity by selective androgen receptor coactivators.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Androgen receptor: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Differential regulation of testosterone vs. 5alpha-dihydrotestosterone by selective androgen response elements

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Interleukin-6 activates phosphatidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Phosphatidylinositol-3 kinase is necessary for 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation and activated protein 1 activation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Interleukin-6 is an autocrine growth factor in human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900792-7

7 January 2021

Identifiers

10.1016/S0006-291X(03)00792-7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43589705&oldid=2101724140"